HIMS
Hims & Hers Health, Inc. Healthcare - Telehealth & Wellness Investor Relations →
Hims & Hers Health, Inc. (HIMS) closed at $22.02 as of 2026-03-20, trading 7.2% above its 200-week moving average of $20.54. The stock is currently moving closer to the line, down from 21.2% last week. With a 14-week RSI of 29, HIMS is in oversold territory.
Over the past 14 weeks, up-weeks have carried more volume than down-weeks (2.66 buyers-vs-sellers ratio). When trading picks up, it's more often on days the price is rising — buyers are showing more interest than sellers.
Over the past 292 weeks of data, HIMS has crossed below its 200-week moving average 6 times. On average, these episodes lasted 21 weeks. Historically, investors who bought HIMS at the start of these episodes saw an average one-year return of +6.7%.
With a market cap of $5.0 billion, HIMS is a mid-cap stock. The company generates a free cash flow yield of 2.2%. Return on equity stands at 25.2%, indicating strong profitability. The stock trades at 9.2x book value.
Share count has increased 9.0% over three years, indicating dilution.
Over the past 5.7 years, a hypothetical investment of $100 in HIMS would have grown to $205, compared to $201 for the S&P 500. That represents an annualized return of 13.5% vs 13.1% for the index — confirming HIMS as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: HIMS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After HIMS Crosses Below the Line?
Across 5 historical episodes, buying HIMS when it crossed below its 200-week moving average produced an average return of +0.2% after 12 months (median -46.0%), compared to +15.0% for the S&P 500 over the same periods. 40% of those episodes were profitable after one year. After 24 months, the average return was +121.2% vs +22.0% for the index.
Each line shows $100 invested at the moment HIMS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
HIMS has crossed below its 200-week MA 6 times with an average 1-year return of +6.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Nov 2020 | Nov 2020 | 1 | 0.1% | -17.5% | +118.0% |
| May 2021 | May 2021 | 2 | 22.3% | -63.1% | +103.9% |
| Jun 2021 | Feb 2023 | 86 | 64.9% | -60.8% | +98.4% |
| Mar 2023 | Mar 2023 | 1 | 0.2% | +59.0% | +145.5% |
| May 2023 | Jan 2024 | 34 | 34.5% | +115.8% | +144.7% |
| Feb 2026 | Mar 2026 | 4 | 28.4% | N/A | +35.1% |
| Average | 21 | — | +6.7% | — |
Frequently Asked Questions
Is HIMS below its 200-week moving average?
No. Hims & Hers Health, Inc. (HIMS) is currently 7.2% above its 200-week moving average of $20.54. It would need to fall to $20.54 to cross below the line.
What is HIMS's 200-week moving average price?
Hims & Hers Health, Inc.'s 200-week moving average is $20.54 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when HIMS drops below its 200-week moving average?
HIMS has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +6.7%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.
Is HIMS a good value right now?
Here's what our data says about HIMS as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 29 (oversold). Free cash flow yield is 2.2%. Return on equity is 25.2%. Price-to-book is 9.2x. This is not a buy or sell recommendation — always do your own research.
How does HIMS compare to the S&P 500?
Over the past 5.7 years, $100 invested in HIMS would have grown to $205, compared to $201 for the S&P 500. That's 13.5% annualized vs 13.1% for the index. HIMS has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20